Michael Rogers
2014 - Acorda Therapeutics
In 2014, Michael Rogers earned a total compensation of $1.3M as Chief Financial Officer former at Acorda Therapeutics, a 70% decrease compared to previous year.
Compensation breakdown
| Bonus | $25,000 |
|---|---|
| Non-Equity Incentive Plan | $221,251 |
| Option Awards | $487,890 |
| Salary | $403,333 |
| Stock Awards | $72,262 |
| Other | $85,630 |
| Total | $1,295,366 |
Rogers received $487.9K in option awards, accounting for 38% of the total pay in 2014.
Rogers also received $25K in bonus, $221.3K in non-equity incentive plan, $403.3K in salary, $72.3K in stock awards and $85.6K in other compensation.
Rankings
In 2014, Michael Rogers' compensation ranked 6,423rd out of 13,032 executives tracked by ExecPay. In other words, Rogers earned more than 50.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,423 out of 13,032 | 51st |
Division Manufacturing | 2,341 out of 4,966 | 53rd |
Major group Chemicals And Allied Products | 785 out of 1,686 | 53rd |
Industry group Drugs | 614 out of 1,365 | 55th |
Industry Biological Products, Except Diagnostic Substances | 118 out of 236 | 50th |
Source: SEC filing on April 21, 2017.
Rogers' colleagues
We found six more compensation records of executives who worked with Michael Rogers at Acorda Therapeutics in 2014.
2014
Andrew Hindman
Acorda Therapeutics
Chief Business Development Officer
2014
Ron Cohen
Acorda Therapeutics
Chief Executive Officer
2014
Jane Wasman
Acorda Therapeutics
General Counsel
2014
Enrique Carrazana
Acorda Therapeutics
Chief Medical Officer
2014
Lauren Sabella
Acorda Therapeutics
Chief Commercial Officer
2014
David Lawrence
Acorda Therapeutics